Cancer

Durvalumab extends survival in stage III non-small cell lung CA

(HealthDay)—Durvalumab results in significantly longer overall survival than placebo among patients with stage III, unresectable non-small cell lung cancer who did not have disease progression after concurrent chemoradiotherapy, ...

Cancer

Larotrectinib: Targeting DNA in cancer therapy

While other toddlers her age were fighting naptime, two-year-old Michelle was battling an aggressive, life-threatening cancer. Doctors at Children's Hospital Los Angeles saved her life in an epic battle, wielding what is ...

Cancer

Major breakthrough in quest for cancer vaccine

The idea of a cancer vaccine is something researchers have been working on for over 50 years, but until recently they were never able to prove exactly how such a vaccine would work.

Cancer

Anti-cancer virus fits tumor receptor like a 'key in a lock'

Seneca Valley virus sounds like the last bug you'd want to catch, but it could be the next breakthrough cancer therapy. Now, scientists at the Okinawa Institute of Science and Technology (OIST) and the University of Otago ...

Cancer

Does work stress increase cancer risk?

In an International Journal of Cancer study of data on more than 280,000 people from North America and Europe, work stress was associated with a significantly increased risk of colorectal, esophagus, and lung cancers.

Cancer

DNA damage leads to genetic diseases and cancer

Scientists have reported that many inheritance mutations are caused by DNA damage rather than errors in DNA doubling. The study was conducted by an international research group and published in Nature Genetics.

page 7 from 23